Assessing breathlessness following pleural fluid drainage using the Visual Analogue Scale for Dyspnoea(VASD) over 1 week(7-DVQ)

R. Banka, E. Mishra
{"title":"Assessing breathlessness following pleural fluid drainage using the Visual Analogue Scale for Dyspnoea(VASD) over 1 week(7-DVQ)","authors":"R. Banka, E. Mishra","doi":"10.1183/13993003.CONGRESS-2018.PA2891","DOIUrl":null,"url":null,"abstract":"Introduction: VASD is a patient reported outcome assessing dyspnea intensity, consisting of a 100mm horizontal line anchored at 0mm with ‘Not breathless at all’ and at 100mm with ‘Worst possible breathlessness’. Although it is a validated measure of dyspnea change with pleural fluid drainage, the optimal duration of measurement following aspiration is not well established and there appears to be a significant placebo effect after 24 hours. Aim: To assess whether routine measurement of 7-DVQ post pleural aspiration is i.acceptable to patients and has a good(>70%)response rate ii. Assess relationship between volume of pleural fluid drained and mean 7-DVQ. Methods: Between Sept 2017 and Jan 2018, consecutive patients undergoing pleural aspiration in pleural clinic at NNUH were enrolled to fill up 7-DVQ. Baseline VASD was recorded before the aspiration and subsequently the patient was asked to complete it at home for 7 days. Results: Of 23 patients who underwent aspiration,17 questionnaires were returned, of which data for analysis were available from 16 patients. Demographics are summarised in Table 1. Mean VASD at baseline and at end of 7 days was 64 mm(SD 28) and 46 mm(SD 21)respectively. Mean decrease in VASD at end of 7 days was 19 mm(SD 14). Correlation between volume of fluid aspirated and decrease in 7-DVQ was 0.5(p=0.03) Conclusion: This study shows that 7-DVQ as a measure to quantify change in dyspnea post aspiration correlates well with amount of fluid aspirated and baseline dyspnea.A response rate of 73% suggests that 7-DVQ is an acceptable measure for patients.","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pleural and Mediastinal Malignancies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA2891","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: VASD is a patient reported outcome assessing dyspnea intensity, consisting of a 100mm horizontal line anchored at 0mm with ‘Not breathless at all’ and at 100mm with ‘Worst possible breathlessness’. Although it is a validated measure of dyspnea change with pleural fluid drainage, the optimal duration of measurement following aspiration is not well established and there appears to be a significant placebo effect after 24 hours. Aim: To assess whether routine measurement of 7-DVQ post pleural aspiration is i.acceptable to patients and has a good(>70%)response rate ii. Assess relationship between volume of pleural fluid drained and mean 7-DVQ. Methods: Between Sept 2017 and Jan 2018, consecutive patients undergoing pleural aspiration in pleural clinic at NNUH were enrolled to fill up 7-DVQ. Baseline VASD was recorded before the aspiration and subsequently the patient was asked to complete it at home for 7 days. Results: Of 23 patients who underwent aspiration,17 questionnaires were returned, of which data for analysis were available from 16 patients. Demographics are summarised in Table 1. Mean VASD at baseline and at end of 7 days was 64 mm(SD 28) and 46 mm(SD 21)respectively. Mean decrease in VASD at end of 7 days was 19 mm(SD 14). Correlation between volume of fluid aspirated and decrease in 7-DVQ was 0.5(p=0.03) Conclusion: This study shows that 7-DVQ as a measure to quantify change in dyspnea post aspiration correlates well with amount of fluid aspirated and baseline dyspnea.A response rate of 73% suggests that 7-DVQ is an acceptable measure for patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用呼吸困难视觉模拟量表(VASD)评估胸腔液引流后1周内的呼吸困难(7-DVQ)
VASD是一种评估呼吸困难强度的患者报告结果,包括100mm水平线锚定在0mm处,“完全不呼吸”,100mm处锚定“最严重的呼吸困难”。虽然它是胸膜液引流后呼吸困难变化的有效测量方法,但吸入后测量的最佳持续时间尚未确定,24小时后似乎有明显的安慰剂效应。目的:评价胸膜穿刺后常规测量7-DVQ是否可被患者接受并具有良好(>70%)的有效率。评估排胸液量与平均7-DVQ的关系。方法:选取2017年9月至2018年1月在NNUH胸膜门诊连续行胸腔抽吸术的患者,填写7-DVQ。在抽吸前记录基线VASD,随后要求患者在家完成7天。结果:23例患者接受误吸治疗,共回收问卷17份,其中有16例患者的数据可供分析。表1概述了人口统计数据。基线和7天结束时的平均VASD分别为64 mm(SD 28)和46 mm(SD 21)。7 d时VASD平均减少19 mm(SD 14)。吸液量与7-DVQ下降的相关性为0.5(p=0.03)。结论:7-DVQ作为衡量吸液后呼吸困难变化的指标,与吸液量和基线呼吸困难有良好的相关性。73%的应答率表明7-DVQ是患者可接受的测量方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comparing the Success Rate of Pleurodesis with Thoracoscopic Talc Poudrage Combined with Indwelling Pleural Catheter versus Thoracoscopic Talc Poudrage in Patient with Malignant Pleural Effusion, A Randomized, Non-inferiority Clinical Trial Patient derived malignant pleural effusion cell cultures as a platform to understand pleural malignancies and advance personalised treatment Variation in outcomes for M1a Stage Lung cacers- Outcome in Malingnat Pleural Effusion significantly worse than patients with Contralateral Lung Nodules Primary cilium modulates mesothelioma cell viability and 3D sphere formation Intracavitary anaesthesia for medical thoracoscopy: a randomised trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1